This study describes real-world treatment patterns of Medicare beneficiaries with relapsed or refractory multiple myeloma (RRMM) who are triple class exposed (TCE).
This study describes real-world treatment patterns of Medicare beneficiaries with relapsed or refractory multiple myeloma (RRMM) who are triple class exposed (TCE).
© 2026 Inovalon.
Need more information or have a specific question? Complete this form and we’ll be happy to show you how our cloud-based solutions can strengthen your operations.
